IQVIA HOLDINGS INC. (IQV)

Services-Commercial Physical & Biological Research

Latest Price

$235.02

TTM P/E

29.20

Normalized P/E

33.92

Div Yield

Book Value

36.94

P/B Ratio

6.36

Valuation metrics

EPS: $7.84

Book value / share: $38.34

Formula: √(22.5 × EPS × BVPS)

Graham Number

$82.24

65% downside

Norm. op. income: $1.8B (median of 7yr)

Tax rate: 18%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$17.70

92% downside

Base FCF: $2.1B (median of recent 5yr)

Growth: 11%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$252.94

+8% upside

EPS: $7.84

Target P/E: 34×

Formula: EPS × P/E

P/E Fair Value

$266.56

+13% upside

89.6% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	15.03M	$2.56B	9.00%	+867.4K	2026-03-31
HARRIS ASSOCIATES L P	12.18M	$2.08B	7.30%	+863.6K	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	11.03M	$1.88B	6.61%	--	2026-03-31
VANGUARD PORTFOLIO MANAGEMENT LLC	7.58M	$1.29B	4.54%	--	2026-03-31
STATE STREET CORP	7.48M	$1.27B	4.48%	+30.1K	2026-03-31
Artisan Partners Limited Partnership	5.06M	$862.0M	3.03%	+1.69M	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	4.46M	$758.0M	2.67%	+88.1K	2026-03-31
Boston Partners	4.24M	$723.0M	2.54%	+151.6K	2026-03-31
Invesco Ltd.	3.26M	$556.0M	1.95%	+780.8K	2026-03-31
ALLIANCEBERNSTEIN L.P.	2.88M	$648.0M	1.72%	-425.1K	2026-03-31